Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 60.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 162.50
  • 52 Week Low: 51.50
  • Currency: UK Pounds
  • Shares Issued: 105.33m
  • Volume: 1,000
  • Market Cap: 63.20m
  • RiskGrade: 315

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (750.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (25.20) (23.40) n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (24.13) (18.90) n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (30.84) (24.93)p n/a n/a n/a n/a 0.0%
31-Dec-20 34.95 (23.67) (12.00)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Verona Pharma Granted Key EU Patent Related to L... 09-Apr-2019 07:00 GlobeNewswire NA
Grant of Options and RSUs and PDMR Dealings 04-Apr-2019 07:00 GlobeNewswire NA
Verona Pharma to Present at H.C. Wainwright Glob... 26-Mar-2019 07:00 GlobeNewswire NA

Latest Verona Pharma Director Deals

Traded Action Notifier PriceAmountValue
22-Mar-19 Buy Piers Morgan 64.00p 20,132 12,884.48
18-Mar-19 Buy Piers Morgan 58.00p 34,481 19,998.98
08-Mar-19 Buy David Ebsworth 57.00p 17,500 9,975.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 60.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 162.50
52 Week Low 51.50
Volume 1,000
Shares Issued 105.33m
Market Cap 63.20m
RiskGrade 315

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.06% below the market average5.06% below the market average5.06% below the market average5.06% below the market average5.06% below the market average
59.32% above the sector average59.32% above the sector average59.32% above the sector average59.32% above the sector average59.32% above the sector average
Price Trend
85.31% below the market average85.31% below the market average85.31% below the market average85.31% below the market average85.31% below the market average
63.93% below the sector average63.93% below the sector average63.93% below the sector average63.93% below the sector average63.93% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for 18-Apr-2019

Time Volume / Share Price
08:23 1,000 @ 60.89p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page